118 related articles for article (PubMed ID: 33983856)
1.
Tissue Eng Part A; 2021 May; 27(9-10):644. PubMed ID: 33983856
[No Abstract] [Full Text] [Related]
2.
Zhang W; Zhang X; Zhang Y; Zhang X; Zou T; Zhao W; Lv Y; Wang J; Dai P; Cui H; Zhang Y; Gao D; Ruan C; Zhang X
Tissue Eng Part A; 2020 Sep; ():. PubMed ID: 32808578
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of Amniotic Scaffold-Seeded Mesenchymal Stem Cells and/or Endothelial Progenitor Cells From Bone Marrow to Efficiently Repair 3-cm Circumferential Urethral Defect in Model Dogs.
Chen C; Zheng S; Zhang X; Dai P; Gao Y; Nan L; Zhang Y
Tissue Eng Part A; 2018 Jan; 24(1-2):47-56. PubMed ID: 28363256
[TBL] [Abstract][Full Text] [Related]
4. Correction to:
Tissue Eng Part A; 2021 May; 27(9-10):642. PubMed ID: 33909493
[No Abstract] [Full Text] [Related]
5. Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector.
Sales VL; Mettler BA; Lopez-Ilasaca M; Johnson JA; Mayer JE
Tissue Eng; 2007 Mar; 13(3):525-35. PubMed ID: 17518601
[TBL] [Abstract][Full Text] [Related]
6. Retraction of:
Tissue Eng Part A; 2020 Apr; 26(7-8):460. PubMed ID: 32286164
[No Abstract] [Full Text] [Related]
7. Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
J Neurochem; 2017 May; 141(3):473-474. PubMed ID: 28417467
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells.
De Coppi P; Callegari A; Chiavegato A; Gasparotto L; Piccoli M; Taiani J; Pozzobon M; Boldrin L; Okabe M; Cozzi E; Atala A; Gamba P; Sartore S
J Urol; 2007 Jan; 177(1):369-76. PubMed ID: 17162093
[TBL] [Abstract][Full Text] [Related]
9. Repair of Bone Defects With Endothelial Progenitor Cells and Bone Marrow-Derived Mesenchymal Stem Cells With Tissue-Engineered Bone in Rabbits.
Zhao X; Han XS; Zhou QZ; Liu BY; Yang B; Gong Z; Wang SM; Wang FK
Ann Plast Surg; 2020 Oct; 85(4):430-436. PubMed ID: 32931683
[TBL] [Abstract][Full Text] [Related]
10. Retraction of:
Tissue Eng Part A; 2020 Jun; 26(11-12):683. PubMed ID: 32434421
[No Abstract] [Full Text] [Related]
11. Defined populations of bone marrow derived mesenchymal stem and endothelial progenitor cells for bladder regeneration.
Sharma AK; Fuller NJ; Sullivan RR; Fulton N; Hota PV; Harrington DA; Villano J; Hagerty JA; Cheng EY
J Urol; 2009 Oct; 182(4 Suppl):1898-905. PubMed ID: 19695585
[TBL] [Abstract][Full Text] [Related]
12. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro.
Alviano F; Fossati V; Marchionni C; Arpinati M; Bonsi L; Franchina M; Lanzoni G; Cantoni S; Cavallini C; Bianchi F; Tazzari PL; Pasquinelli G; Foroni L; Ventura C; Grossi A; Bagnara GP
BMC Dev Biol; 2007 Feb; 7():11. PubMed ID: 17313666
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived stem cells in wound healing: a review.
Wu Y; Wang J; Scott PG; Tredget EE
Wound Repair Regen; 2007; 15 Suppl 1():S18-26. PubMed ID: 17727462
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal progenitor cells from canine fetal tissues: yolk sac, liver, and bone marrow.
Wenceslau CV; Miglino MA; Martins DS; Ambrósio CE; Lizier NF; Pignatari GC; Kerkis I
Tissue Eng Part A; 2011 Sep; 17(17-18):2165-76. PubMed ID: 21529262
[TBL] [Abstract][Full Text] [Related]
15. Are Amniotic Fluid Products Stem Cell Therapies? A Study of Amniotic Fluid Preparations for Mesenchymal Stem Cells With Bone Marrow Comparison.
Panero AJ; Hirahara AM; Andersen WJ; Rothenberg J; Fierro F
Am J Sports Med; 2019 Apr; 47(5):1230-1235. PubMed ID: 30844295
[TBL] [Abstract][Full Text] [Related]
16. Osteogenic Differentiation Potential of Human Bone Marrow and Amniotic Fluid-Derived Mesenchymal Stem Cells in Vitro & in Vivo.
Mohammed EEA; El-Zawahry M; Farrag ARH; Aziz NNA; Sharaf-ElDin W; Abu-Shahba N; Mahmoud M; Gaber K; Ismail T; Mossaad MM; Aleem AKA
Open Access Maced J Med Sci; 2019 Feb; 7(4):507-515. PubMed ID: 30894903
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment.
Lange-Consiglio A; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
Equine Vet J; 2013 Nov; 45(6):737-44. PubMed ID: 23527626
[TBL] [Abstract][Full Text] [Related]
18. Retraction: Zhang, K., et al. Knockdown of Snail Sensitizes Pancreatic Cancer Cells to Chemotherapeutic Agents and Irradiation. Int. J. Mol. Sci. 2010, 11, 4891-4904, doi:10.3390/ijms11124891 and Zhang, K., et al. RNA Interference Targeting Slug Increases Cholangiocarcinoma Cell Sensitivity to Cisplatin via Upregulating PUMA. Int. J. Mol. Sci. 2011, 12, 385-400, doi:10.3390/ijms12010385.
International Journal of Molecular Sciences Editorial office
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698505
[No Abstract] [Full Text] [Related]
19. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
[TBL] [Abstract][Full Text] [Related]
20. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
